Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Motion Sickness Medicine Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4311535
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 106 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Motion Sickness Medicine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Motion Sickness Medicine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Anticholinergic
Antihistamines
Others

Segmented by End User/Segment
Adults
Children

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
GlaxoSmithKline
Prestige Brands
Mylan 
Baxter International
Caleb Pharmaceuticals
Myungmoon Pharm
Pfizer
WellSpring Pharmaceutical Corporation
Sandoz


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Motion Sickness Medicine Market Status and Forecast (2016-2027)
      • 1.3.2 Global Motion Sickness Medicine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Motion Sickness Medicine Supply by Company

    • 2.1 Global Motion Sickness Medicine Sales Volume by Company
    • 2.2 Global Motion Sickness Medicine Sales Value by Company
    • 2.3 Global Motion Sickness Medicine Price by Company
    • 2.4 Motion Sickness Medicine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Motion Sickness Medicine Market Status by Category

    • 3.1 Motion Sickness Medicine Category Introduction
      • 3.1.1 Anticholinergic
      • 3.1.2 Antihistamines
      • 3.1.3 Others
    • 3.2 Global Motion Sickness Medicine Market by Category
      • 3.2.1 Global Motion Sickness Medicine Sales Volume by Category (2016-2021)
      • 3.2.2 Global Motion Sickness Medicine Sales Value by Category (2016-2021)
      • 3.2.3 Global Motion Sickness Medicine Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Motion Sickness Medicine Market Status by End User/Segment

    • 4.1 Motion Sickness Medicine Segment by End User/Segment
      • 4.1.1 Adults
      • 4.1.2 Children
    • 4.2 Global Motion Sickness Medicine Market by End User/Segment
      • 4.2.1 Global Motion Sickness Medicine Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Motion Sickness Medicine Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Motion Sickness Medicine Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Motion Sickness Medicine Market Status by Region

    • 5.1 Global Motion Sickness Medicine Market by Region
      • 5.1.1 Global Motion Sickness Medicine Sales Volume by Region
      • 5.1.2 Global Motion Sickness Medicine Sales Value by Region
    • 5.2 North America Motion Sickness Medicine Market Status
    • 5.3 Europe Motion Sickness Medicine Market Status
    • 5.4 Asia Pacific Motion Sickness Medicine Market Status
    • 5.5 Central & South America Motion Sickness Medicine Market Status
    • 5.6 Middle East & Africa Motion Sickness Medicine Market Status

    6 North America Motion Sickness Medicine Market Status

    • 6.1 North America Motion Sickness Medicine Market by Country
      • 6.1.1 North America Motion Sickness Medicine Sales Volume by Country (2016-2021)
      • 6.1.2 North America Motion Sickness Medicine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Motion Sickness Medicine Market Status

    • 7.1 Europe Motion Sickness Medicine Market by Country
      • 7.1.1 Europe Motion Sickness Medicine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Motion Sickness Medicine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Motion Sickness Medicine Market Status

    • 8.1 Asia Pacific Motion Sickness Medicine Market by Country
      • 8.1.1 Asia Pacific Motion Sickness Medicine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Motion Sickness Medicine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Motion Sickness Medicine Market Status

    • 9.1 Central & South America Motion Sickness Medicine Market by Country
      • 9.1.1 Central & South America Motion Sickness Medicine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Motion Sickness Medicine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Motion Sickness Medicine Market Status

    • 10.1 Middle East & Africa Motion Sickness Medicine Market by Country
      • 10.1.1 Middle East & Africa Motion Sickness Medicine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Motion Sickness Medicine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Motion Sickness Medicine Distributors
    • 11.3 Motion Sickness Medicine Buyers

    12 Global Motion Sickness Medicine Market Forecast by Category and by End User/Segment

    • 12.1 Global Motion Sickness Medicine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Motion Sickness Medicine Forecast by Category
      • 12.2.1 Global Motion Sickness Medicine Sales Volume Forecast by Category
      • 12.2.2 Global Motion Sickness Medicine Sales Value Forecast by Category
      • 12.2.3 Global Motion Sickness Medicine Price Forecast by Category
    • 12.3 Global Motion Sickness Medicine Forecast by End User/Segment
      • 12.3.1 Global Motion Sickness Medicine Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Motion Sickness Medicine Sales Value Forecast by End User/Segment
      • 12.3.3 Global Motion Sickness Medicine Price Forecast by End User/Segment

    13 Global Motion Sickness Medicine Market Forecast by Region/Country

    • 13.1 Global Motion Sickness Medicine Market Forecast by Region (2022-2027)
      • 13.1.1 Global Motion Sickness Medicine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Motion Sickness Medicine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 GlaxoSmithKline
      • 14.1.1 Company Information
      • 14.1.2 Motion Sickness Medicine Product Introduction
      • 14.1.3 GlaxoSmithKline Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Prestige Brands
      • 14.2.1 Company Information
      • 14.2.2 Motion Sickness Medicine Product Introduction
      • 14.2.3 Prestige Brands Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Mylan
      • 14.3.1 Company Information
      • 14.3.2 Motion Sickness Medicine Product Introduction
      • 14.3.3 Mylan Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Baxter International
      • 14.4.1 Company Information
      • 14.4.2 Motion Sickness Medicine Product Introduction
      • 14.4.3 Baxter International Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Caleb Pharmaceuticals
      • 14.5.1 Company Information
      • 14.5.2 Motion Sickness Medicine Product Introduction
      • 14.5.3 Caleb Pharmaceuticals Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Myungmoon Pharm
      • 14.6.1 Company Information
      • 14.6.2 Motion Sickness Medicine Product Introduction
      • 14.6.3 Myungmoon Pharm Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Pfizer
      • 14.7.1 Company Information
      • 14.7.2 Motion Sickness Medicine Product Introduction
      • 14.7.3 Pfizer Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 WellSpring Pharmaceutical Corporation
      • 14.8.1 Company Information
      • 14.8.2 Motion Sickness Medicine Product Introduction
      • 14.8.3 WellSpring Pharmaceutical Corporation Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Sandoz
      • 14.9.1 Company Information
      • 14.9.2 Motion Sickness Medicine Product Introduction
      • 14.9.3 Sandoz Motion Sickness Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information

    15 Conclusion

    Summary:
    Get latest Market Research Reports on Motion Sickness Medicine. Industry analysis & Market Report on Motion Sickness Medicine is a syndicated market report, published as Dynamics in Post-pandemic Global Motion Sickness Medicine Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Motion Sickness Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,395.92
    3,593.88
    4,791.84
    2,786.30
    4,179.45
    5,572.60
    461,035.80
    691,553.70
    922,071.60
    248,323.40
    372,485.10
    496,646.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report